Join Other Proton Alums and Caregivers and Tell Elected Representatives to Exclude Proton Therapy from Medicare’s RO APM
The Centers for Medicare and Medicaid Services, or CMS, recently announced final plans to implement in January an experimental reimbursement policy that will drastically reduce Medicare payments for proton therapy services for a select group of providers. Unfortunately, the UF Health Proton Therapy Institute (UFHPTI) has been randomly selected to participate in this experiment. The experiment, referred to as the Radiation Oncology Alternative Payment Model, or RO APM, will force UFHPTI to face very serious financial challenges in continuing to achieve our mission of providing excellent patient care and research.
RO APM UPDATE
Your voice is making a difference! On December 9, 2021, Congress passed a bill postponing the implementation of reimbursement cuts, including Medicare's RO APM, until January 2023.
Thank you for all you've done to reach out in support of the proton therapy community. We are hopeful that by continuing to share our stories and evidence-based research showing the true value of proton therapy, we will succeed.
Make your voice heard - reach out using the information below.
Here’s How You Can Help Today
Speak up and tell your elected representatives in the White House and Congress to exclude proton therapy from the Radiation Oncology Alternative Payment Model, or RO APM.
- Contact President Biden and ask him to instruct CMS to exclude proton therapy from the RO APM.
Download a sample letter that you can personalize: PDF | Word Doc
- Ask your congressional representatives to urge President Biden to instruct CMS to exclude proton therapy from the RO APM.
Download a sample letter that you can personalize: PDF | Word Doc
Read Florida Congressional Delegation Letter to Medicare for Inspiration
Read MoreWe sincerely appreciate any assistance you can provide to help secure the future of proton therapy and UFHPTI. Thank you for your support and continued advocacy on behalf of the UF Health Proton Therapy Institute.